« Previous
Next »
Titles
- Enrichment strategies for clinical trials to support determination of effectiveness of human drugs and biological products1
- Eosinophilic esophagitis: developing drugs for treatment1
- Epidermolysis bullosa: developing drugs for treatment of cutaneous manifestations1
- Establishing effectiveness for drugs intended to treat male hypogonadotropic hypogonadism attributed to nonstructural disorders1
- Establishing the performance characteristics of in vitro diagnostic devices for the detection or detection and differentiation of human papillomaviruses: guidance for Industry and Food and Drug Administration staff1
- Evaluating drug effects on the ability to operate a motor vehicle1
- Evaluation and reporting of age-, race-, and ethnicity-specific data in medical device clinical studies: guidance for Industry and Food and Drug Administration staff1
- Evaluation of devices used with regenerative medicine advanced therapies1
- Evaluation of internal standard responses during chromatographic bioanalysis: questions and answers1
- Expiration dating of unit-dose repackaged solid oral dosage form drug products1
- Extending expiration dates of doxycycline tablets and capsules in strategic stockpiles: guidance for government public health and emergency response stakeholders1
- Extension of certain tobacco product compliance deadlines related to the final deeming rule: (revised)2